Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Vinorelbine × Vinorelbine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Triple Negative Breast Neoplasms 3 Rhabdomyosarcoma 2 Vinorelbine 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Neoplasms 1 Neoplasm Metastasis 1 HR+HER2- Breast Cancer 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540950 2024-08-07

Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Active not recruiting

Vinorelbine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡